Guidance

Kerosene: toxicological overview

Updated 14 October 2024

Main points

Kinetics and metabolism

As kerosene is a mixture of chemicals, there is no definitive ADME (absorption, distribution, metabolism, and excretion) data.

Limited data from metabolism studies suggest that kerosene is removed from circulation by the liver and lungs.

Health effects of acute exposure

The major route of exposure is by inhalation of liquid (aspiration).

Kerosene vapours may be mildly irritating to the respiratory system and spray applications of kerosene may provoke signs of pulmonary irritation such as coughing and dyspnoea.

Acute dermal exposure may result in local irritation, but it is not considered to be a skin sensitiser.

Acute exposure to kerosene may result in CNS effects including irritability, restlessness, ataxia, drowsiness, convulsions, coma and death.

Health effects of chronic exposure

The most common health effect associated with chronic kerosene exposure is dermatitis, usually associated with inappropriate use of personal protective equipment.

Chronic exposure may also cause non-specific CNS effects such as nervousness, loss of appetite and nausea.

Kerosene does not have a measurable effect on human reproduction or development.

IARC concluded that there was inadequate evidence to classify kerosene as a human carcinogen.

Summary of health effects

The principal adverse effect arising from ingestion of kerosene is chemical pneumonitis secondary to aspiration of vomitus. Ingestion of kerosene or acute exposure to vapour may lead to general signs of intoxication such as mild CNS symptoms (dizziness, headache, nausea) and vomiting. Skin exposure to kerosene may result in dermatitis through the extraction of endogenous skin lipids. Whilst kerosene is not considered a direct-acting dermal carcinogen, chronic skin exposure may result in tumourigenesis.

Kinetics and metabolism

As kerosene is a mixture of chemicals, there is no definitive ADME (absorption, distribution, metabolism, and excretion) data.

Absorption

Two studies have indicated poor oral availability in the baboon and dog (1, 2).

Individual components of kerosene are known to undergo dermal absorption (3-6) and kerosene vapour is absorbed following pulmonary exposure (7). The extent of dermal and pulmonary absorption is dose and time-dependent (8).

Distribution

A limited number of (primate) metabolism studies suggest that kerosene is efficiently removed from the circulation by the liver and lungs (9).

Excretion

There is currently no information on the elimination kinetics of kerosene.

Sources and Route of Human Exposure

Kerosene is a liquid mixture of hydrocarbons (chain length C₉ – C₁₆) produced by the distillation of crude oil. The preferred Chemical Abstracts spelling is ‘kerosine’. The (UK) technical term for kerosene is ‘C2 Fuel Oil’ (Annex I), as it is derived from the ‘kerosene’ fraction of distilled crude oil. Older, flue-less appliances use ‘paraffin’ (C1) fuel.

The general composition of C2 fuel oil is given at Annex II: For the purpose of this document, kerosene will be used as a synonym for C2 domestic fuel oil. It is important to note that kerosene is not a synonym for ‘jet fuels’ (which are a distinct class of petroleum distillate product containing a range of chemical additives).

The main route of exposure to kerosene causing toxicity is via inhalation during ingestion (aspiration). Acute, oral exposures may occur from accidental or intentional ingestion. Inhalation or dermal absorption of kerosene may occur through occupational exposures (petrochemical and aviation sectors), from the use of commercially-available products such as paints and insecticides, via accidental release (road traffic incidents) or through substance abuse. Contaminated water may represent a substantial aspiration risk during whole-body immersion (swimming or near-drowning).

Health effects of acute or single exposure

Human data

General toxicity

The acute health risks involved in handling and using kerosene are minimal, provided that the product(s) are used in accordance with current safety practices (10). The main hazard associated with kerosene is chemical pneumonitis, resulting from aspiration of vomitus following ingestion (11) or inhalation of kerosene liquid or contaminated water. A rare complication of kerosene intoxication may be cardiac arrhythmia and ventricular fibrillation, attributed to increased myocardial sensitivity to endogenous catecholamines (8).

Inhalation

Whilst kerosene vapours may be mildly irritating to the respiratory system (8), exposure is not likely to be fatal (7) as the low volatility of kerosene (12) limits air concentrations to below 100mg m^-3 (13), which is the approximate NOAEL (no-observed adverse effect level) in several animal species (7). However, exposure within a confined space at elevated temperature may induce narcotic effects such as narcolepsy, cataplexy, and confusion (8, 14) and there is one report of a fatal (vapour) exposure in a child (15).

Spray applications may result in exposure to high concentrations of kerosene aerosol (16) which may provoke signs of pulmonary irritation such as coughing and dyspnoea (14), in addition to mild CNS depression.

Inhalation of water contaminated with kerosene may occur when swimming or as a result of near-drowning incidents and has been associated with “exogenous lipoid pneumonia” (17).

Aspiration of kerosene-contaminated vomitus is a secondary source of pulmonary exposure that may lead to chemical (lipoidal) pneumonitis (18), a delayed onset and potentially fatal lung disorder characterised by cyanosis, dyspnoea, and chest x-ray opacities (19).

Ingestion

Signs of oral kerosene poisoning include diarrhoea, nausea and vomiting. Approximately 30 to 50% of children presenting with suspected kerosene ingestion are asymptomatic (7).

Children have survived ingestion of up to 1.7g kg^-1 and recorded instances of fatal poisoning have been associated with doses ranging from ~ 2 to 17g kg^-1 (7, 20, 21). However, death following oral exposure is normally associated with aspiration of vomit rather than systemic toxicity per se; vomiting occurs in approximately one third to one half of patients (22).

Dermal or ocular exposure

Kerosene is a mild, transient ocular irritant that may produce conjunctivitis, hyperaemia, and lacrimation (3, 14).

Acute dermal exposure may result in local irritation (erythema, pruritis) but is not considered to be a skin sensitiser (3). A small proportion of individuals (<5%) may exhibit hyper-sensitivity to kerosene and skin contact may result in “burn-like” injuries (23-25): histological analysis of full-blown pustular eruptions has shown inter- and intra-cellular oedema with intra-epidermal vesicles (25, 26). It is conceivable that hypersensitivity may be the result of concurrent dermatitis resulting in “excited skin syndrome” (“angry back syndrome”) (27).

Neurotoxicity

Acute exposure to kerosene in humans has been associated with a variety of CNS effects, including irritability, restlessness, ataxia, drowsiness, convulsions, coma and death (13); these are generally considered to be secondary effects resulting from hypoxia (28). Lethargy and “other CNS complications” were reported in ~5% of volunteers ingesting 10 to 30ml of kerosene (13).

Delayed effects following acute exposure

There is limited evidence to suggest that long-term pulmonary residual effects may occur following chemical pneumonitis (18, 22). These effects are considered minor and are of unknown clinical relevance (12).

Animal data and in-vitro data

General toxicity

The oral toxicity (LD₅₀) of kerosene in a variety of laboratory animals is of the order 20 to 30g kg^-1 (7, 29). Intra-tracheal dosing of kerosene liquid (which models the aspiration of vomit in humans) results in a substantial (10- to 150-fold) increase in toxicity and is consistent with known human health effects. However, studies with monkeys (unspecified strain) and guinea pigs have indicated that lung pathology may occur following oral or parenteral exposure to kerosene, although this effect is not reproducible in all species (7, 29). It has not been possible to determine a LCt₅₀ for kerosene vapour due to its relatively low volatility: An 8-hour exposure to saturated (deodorised) kerosene vapour in dogs, cats or rats did not result in mortality (30).

Delayed effects following acute exposure

The available literature pertaining to the long-term effects of kerosene following acute exposure is mainly concerned with jet fuels (13, 31) and thus its relevance is uncertain due to the presence of chemical additives. In general, single (acute) oral, dermal, and ocular exposures do not result in persistent effects.

Health effects following chronic or repeated exposure

Human data

General toxicity

The most common health effect associated with chronic / repeated kerosene exposure is dermatitis (31) which may be associated with insufficient or inappropriate use of personal protective equipment (PPE) in occupational environments. Lung effects (such as dyspnoea) have been reported but tend to be associated with ‘high-level’ exposures (31). It is conceivable that similar lung and skin effects may be observed in some individuals following a single, acute exposure.

Inhalation

There are currently no unequivocal studies to relate chronic or repeated kerosene exposures to long-term pulmonary dysfunction (other than that putatively associated with aspiration of contaminated water or vomit). There is limited evidence to suggest that chronic exposure may be associated with a tightness of chest and breathing difficulties, although a review of the duration and extent of exposure in such studies was not reported (31).

Ingestion

Chronic, oral exposure to kerosene is unlikely to arise under normal circumstances and there is currently no human data on the chronic effects of kerosene ingestion.

Dermal or ocular exposure

Chronic skin exposure to kerosene is known to cause dermatitis: Table 1 summarises the result of a dermatological study of ball-bearing workers (n=79) exposed on a daily basis to kerosene.

Table 1: Summary of lesion severity (as a function of overt skin pathology), expressed as a percentage of a total factory population (25, 32).

Lesion Severity	Corresponding Sign	% Presenting
Absent	Asymptomatic	16
Low	Erythema	65
Moderate	Eczematous lesions	15
Severe	Defatting dermatitis	4

Neurotoxicity

Long-term exposures to ‘low’ concentrations of kerosene have been reported to produce non-specific CNS effects such as nervousness, loss of appetite and nausea that are not related to hypoxia (13).

Genotoxicity

An increase in cytogenetic changes (chromosomal aberrations in peripheral lymphocytes and bone-marrow micronuclei) has been reported in a limited study of workers exposed to a mixture of kerosene, bunker fuels, white spirit and xylene (33). However, the mixed exposure precludes any specific conclusions and the results do not correlate with the effects of kerosene-only exposure in animals or in vitro mutagenicity tests.

Carcinogenicity

An excess of lung cancer was seen in a large cohort of Japanese workers exposed to kerosene, diesel oil, crude petroleum and mineral oil (29). In another Japanese study, an excess of stomach cancer was observed amongst workers possibly exposed to kerosene, machine oil or grease (29). Three case-control studies found an association between lung cancer and the use of kerosene stoves for cooking amongst women in Hong Kong; however, no distinction was made between exposure to kerosene per se and exposure to its combustion products (29). Given that such studies could not attribute the effects to a particular chemical, the IARC evaluated mid-distillate fuel oils as being “not classifiable as to their carcinogenicity to humans (Group 3)” (29): there is “inadequate evidence” to classify kerosene as a human carcinogen and “limited evidence” for the carcinogenicity of kerosene to experimental animals.

Reproductive and developmental toxicity

Current evidence indicates that kerosene does not have a measurable effect on human reproduction or development (3). This is in accordance with animal studies.

Animal data

General toxicity

In general, animal data is in accordance with the known human effects of kerosene.

Inhalation

Pulmonary pathology (inflammatory cell infiltrates and morphological changes to tracheal epithelia) and cardiovascular changes (resembling atherosclerosis) have been observed in guinea pigs following exposure to high concentrations (up to 34g m^-3) of kerosene aerosol for 15 minutes per day over a three-week period (34-36). Continuous (3 month) exposure of rats and mice to up to 1g m^-3 aviation fuel (JP-8) vapour resulted in male rat-specific pathology (nephropathy) that was not thought to be of relevance to humans (37).

Ingestion

No studies on the chronic effects of oral exposure to kerosene were identified. In a study with JP-8 jet fuel, male rat-specific effects (α-2-microglobulin nephropathy) were noted following three-month oral gavage (up to 3g kg^-1) (38). Interestingly, there were also effects that were not species-specific, including perianal dermatitis and gastritis. However, it should be noted that JP-8 contains a variety of chemical moieties in addition to those associated with kerosene.

Dermal / ocular exposure

Dermatitis was observed in mice topically exposed to kerosene (applied in muslin cloth) for 15 to 60 minutes each day for one week which resolved within three weeks (39). Pathological changes (hyperplasia and visual scores of irritation) were also observed in mice exposed twice a week for two weeks to deodorised kerosene, but the lesion severity did not correlate with tumour-promoting activity when compared against four other petroleum products (40). When applied three times a week for up to six weeks, repeated cycles of necrosis and regeneration were observed that were deemed sufficient to represent an epigenetic mechanism for tumourigenesis.

Genotoxicity

Negative results were obtained when kerosene was investigated for its ability to induce gene mutation using Salmonella typhimurium TA98 or TA100, with and without an exogenous metabolic activation system (29).

Negative results were also obtained in a mammalian cell assay, using the mouse lymphoma L5178Y TK+/- cells (also in the presence or absence of metabolic activation) (29).

There is one report of an in vivo assay investigating the ability of kerosene to induce chromosomal aberrations in the bone marrow of rats using the intra-peritoneal route of administration (single dose or daily for five days). No aberrations were observed (29).

Together, these data imply that kerosene does not have any significant mutagenic activity.

Carcinogenicity

There is limited evidence from skin-painting studies that kerosene can induce skin tumours in mice and the IARC concluded that there was limited evidence in animals for the carcinogenicity of straight-run kerosene and fuel oil (29).

It is recognised that kerosene does not have any significant mutagenic potential and that the tumorigenic activity of middle distillate fuels (including kerosene) is likely a result of a non-genotoxic processes resulting from chronic irritation (8, 14, 29, 31, 41, 42).

Reproductive and developmental toxicity

Deodorised kerosene was assessed using OECD (Organisation for Economic Cooperation and Development) Guideline 421 for reprotoxic or developmental effects in rats (43). The evaluation involved dermal exposure to up to 494mg kg^-1 day-1 for up to 8 weeks. No pathological effects were observed on reproductive organs and no excessive anomalies were found in the first generation of pups. The authors concluded that the NOAEL for deodorised kerosene was 494mg kg^-1 day^-1. Kerosene (unspecified grade) was also investigated in a developmental toxicity study in rats using inhalation exposure of up to 315ppm (2.55g m^-3): no teratogenic effects were noted (44).

References 

[1] Wolfe, B. M., Brodeur, A. E. and Shields, J. B. (1970). The role of gastrointestinal absorption of kerosene in producing pneumonitis in dogs. J Pediatr 76, 867-73.

[2] Mann, M. D., Pirie, D. J. and Wolfsdorf, J. (1977). Kerosene absorption in primates. J Pediatr 91, 495-8.

[3] Koschier, F. J. (1999). Toxicity of middle distillates from dermal exposure. Drug Chem Toxicol 22, 155-64.

[4] Mattorano, D. A., Kupper, L. L. and Nylander-French, L. A. (2004). Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg 48, 139-46.

[5] Riviere, J. E., Brooks, J. D., Monteiro-Riviere, N. A., Budsaba, K. and Smith, C. E. (1999). Dermal absorption and distribution of topically dosed jet fuels jet-A, JP-8, and JP-8(100). Toxicol Appl Pharmacol 160, 60-75.

[6] Singh, S., Zhao, K. and Singh, J. (2003). In vivo percutaneous absorption, skin barrier perturbation, and irritation from JP-8 jet fuel components. Drug Chem Toxicol 26, 135-46.

[7] Risher, J. F. and Rhodes, S. W. (1995). Toxicological profiles for fuel oils. US Department of Health and Human Services.

[8] Bebarta, V. and DeWitt, C. (2004). Miscellaneous hydrocarbon solvents. Clin Occup Environ Med 4, 455-79, vi.

[9] Wolfsdorf, J. and Paed, D. (1976). Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr 88, 1037-40.

[10] Henry, J. A. (1998). Copmposition and toxicity of petroleum products and their additives. Human and Experimental Toxicology 17, 111-123.

[11] National Poisons Information Service (NPIS) (2003). Kerosene. TOXBASE®.

[12] Seymour, F. K. and Henry, J. A. (2001). Assessment and management of acute poisoning by petroleum products. Human and Experimental Toxicology 20, 551-562.

[13] Ritchie, G. D., Still, K. R., Alexander, W. K., Nordholm, A. F., Wilson, C. L., Rossi, J., 3rd and Mattie, D. R. (2001). A review of the neurotoxicity risk of selected hydrocarbon fuels. J Toxicol Environ Health B Crit Rev 4, 223-312.

[14] Conservation of Clean Air and Water in Europe (CONCAWE) (1995). Kerosines / jet fuels. Product Dossier No. 94/106.

[15] Moller, J. C., Vardag, A. M., Jonas, S. and Tegtmeyer, F. K. (1992). [Poisoning with volatile hydrocarbons. 3 cases and a review]. Monatsschr Kinderheilkd 140, 113-6.

[16] Conservation of Clean Air and Water in Europe (CONCAWE) (1985). Health aspects of petroleum fuels. Potential hazards and precautions for individual classes of fuel. Report No. 85/51.

[17] Segev, D., Szold, O., Fireman, E., Kluger, Y. and Sorkine, P. (1999). Keroseneinduced severe acute respiratory failure in near drowning: reports on four cases and review of the literature. Crit Care Med 27, 1437-40.

[18] Eade, N. R., Taussig, L. M. and Marks, M. I. (1974). Hydrocarbon pneumonitis. Pediatrics 54, 351-7.

[19] Mabie, M. and Wunderink, R. G. (2003). Use and limitations of clinical and radiologic diagnosis of pneumonia. Semin Respir Infect 18, 72-9.

[20] Dudin, A. A., Rambaud-Cousson, A., Thalji, A., Jubeh, II, Ahmad, H. M. and Libdeh, B. A. (1991). Accidental kerosene ingestion: a 3-year prospective study. Ann Trop Paediatr 11, 155-61.

[21] Santhanakrishnan, B. R. and Chithra, S. (1978). Accidental kerosene poisoning in infants and children. Indian J Pediatr 45, 265-73.

[22] Litovitz, T. and Greene, A. E. (1988). Health implications of petroleum distillate ingestion. Occup Med 3, 555-68.

[23] Mosconi, G., Migliori, M., Greco, V. and Valsecchi, R. (1988). Kerosene “burns”: a new case. Contact Dermatitis 19, 314-5.

[24] Nussinovitch, M., Amir, J. and Varsano, I. (1992). Chemical pneumonia and dermatitis caused by kerosene. Clin Pediatr (Phila) 31, 574.

[25] Tagami, H. and Ogino, A. (1973). Kerosine dermatitis. Factors affecting skin irritability to kerosine. Dermatologica 146, 123-31.

[26] Lupulescu, A. P. and Birmingham, D. J. (1976). Effect of protective agent against lipid-solvent-induced damages. Ultrastructural and scanning electron microscopical study of human epidermis. Arch Environ Health 31, 33-6.

[27] Nethercott, J. R. and Lawrence, M. (1983). The effect of the guinea pig maximization protocol on the irritant response to deodorized kerosene - the excited skin syndrome. Contact Dermatitis 9, 439-43.

[28] Majeed, H. A., Bassyouni, H., Kalaawy, M. and Farwana, S. (1981). Kerosene poisoning in children: a clinico-radiological study of 205 cases. Ann Trop Paediatr 1, 123-30.

[29] International Agency for the Research on Cancer (IARC) (1989). Occupational exposures in petroleum refining: Crude oil and major petroleum fuels. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon.

[30] Carpenter, C. P., Geary, D. L., Jr., Myers, R. C., Nachreiner, D. J., Sullivan, L. J. and King, J. M. (1976). Petroleum hydrocarbon toxicity studies. XI. Animal and human response to vapors of deodorized kerosene. Toxicol Appl Pharmacol 36, 443-56.

[31] Ritchie, G., Still, K., Rossi, J., 3rd, Bekkedal, M., Bobb, A. and Arfsten, D. (2003). Biological and health effects of exposure to kerosene-based jet fuels and performance additives. J Toxicol Environ Health B Crit Rev 6, 357-451.

[32] Jee, S. H., Wang, J. D., Sun, C. C. and Chao, Y. F. (1986). Prevalence of probable kerosene dermatoses among ball-bearing factory workers. Scand J Work Environ Health 12, 61-5.

[33] Hogstedt, B., Gullberg, B., Mark-Vendel, E., Mitelman, F. and Skerfving, S. (1981). Micronuclei and chromosome aberrations in bone marrow cells and lymphocytes of humans exposed mainly to petroleum vapors. Hereditas 94, 179-87.

[34] Noa, M., Illnait, J. and Gonzalez, R. (1985). Cytologic and biochemical changes in pulmonary washings of guinea pigs exposed to kerosene. Allergol Immunopathol (Madr) 13, 193-6.

[35] Noa, N. and Sanabria, J. (1984). Tracheal ultrastructure in kerosene treated guinea pigs. A preliminary report. Allergol Immunopathol (Madr) 12, 33-6.

[36] Noa, M. and Illnait, J. (1987). Induction of aortic plaques in guinea pigs by exposure to kerosene. Arch Environ Health 42, 31-6.

[37] Mattie, D. R., Alden, C. L., Newell, T. K., Gaworski, C. L. and Flemming, C. D. (1991). A 90-day continuous vapor inhalation toxicity study of JP-8 jet fuel followed by 20 or 21 months of recovery in Fischer 344 rats and C57BL/6 mice. Toxicol Pathol 19, 77- 87.

[38] Mattie, D. R., Marit, G. B., Flemming, C. D. and Cooper, J. R. (1995). The effects of JP-8 jet fuel on male Sprague-Dawley rats after a 90-day exposure by oral gavage. Toxicol Ind Health 11, 423-35.

[39] Upreti, R. K., Das, M. and Shanker, R. (1989). Dermal exposure to kerosene. Vet Hum Toxicol 31, 16-20.

[40] Walborg, E. F., Jr., DiGiovanni, J., Conti, C. J., Slaga, T. J., Freeman, J. J., Steup, D. R. and Skisak, C. M. (1998). Short-term biomarkers of tumor promotion in mouse skin treated with petroleum middle distillates. Toxicol Sci 45, 137-45.

[41] Ingram, A. J., King, D. J., Grasso, P. and Sharratt, M. (1993). The early changes in mouse skin following topical application of a range of middle distillate oil products. J Appl Toxicol 13, 247-57.

[42] Nessel, C. S. (1999). A comprehensive evaluation of the carcinogenic potential of middle distillate fuels. Drug Chem Toxicol 22, 165-80.

[43] Schreiner, C., Bui, Q., Breglia, R., Burnett, D., Koschier, F., Podhasky, P., Lapadula, L., White, R., Feuston, M., Krueger, A. and Rodriquez, S. (1997). Toxicity evaluation of petroleum blending streams: reproductive and developmental effects of hydrodesulfurized kerosine. J Toxicol Environ Health 52, 211-29.

[44] Schreiner, C. (1984) Petroleum and petroleum products: a brief review of studies to evaluate reproductive effects. Princeton Scientific Publishers, Princeton

[45] Anon (1998). Specification for fuel oils for agricultural, domestic and industrial engines and boilers. British Standard 2869:1998.

[46] Potter, T. L. and Simmons, K. E. (1998). Composition of chemical mixtures. Total Petroleum Hydrocarbon Criteria Working Group Series 2.

Email chemcompendium@ukhsa.gov.uk if you have any questions about this guidance or enquiries@ukhsa.gov.uk if you have any other questions.

Feedback Survey

Help us improve the compendium of chemical hazards by taking our short survey.